Specialty Natural Products Public Company Limited
SNPS
Rank in Stocks
#22402
Specialty Natural Products Public Company Limited manufactures and distributes... Specialty Natural Products Public Company Limited manufactures and distributes herbal extracts, cosmetics, beverages, health supplements, and traditional medicines in Thailand and internationally. The company also offers extracts for nutraceuticals and cosmeceuticals for use in weight and immune control, blood pressure and sugar, antiaging, hair nourishment, whitening, wound healing, UV protection, rejuvenation for men, slimming, cosmetic mosturerizing, antibacterial, antioxidant, nutrition, and anti-inflammatory; natural additives, such as eucalyptus, ginger, jojoba, kaffir lime, lavender, lemon, lemongrass, lime, orange, peppermint, plai, turmeric, rice bran, and tea tree oil; and other additives, including amino cleansers, concentrate shampoo, SNP-alpha arbutin, Argirena, clear soap, cremaflow, emulbase, ICM, nonawax, polyol complex, solubilisant, standard EB, surfactant base1, sunsil tin50, tiospere 50BG, TOG, supersil E, and standard EB. In addition, it provides herbal active pharmaceuticals ingredients comprising senna extract liquid and andrographis extract powder; packing services for cosmetics, beverages, and dietary supplements; production and distribution of electricity; and product research and development services. The company was incorporated in 1999 and is headquartered in Chonburi, Thailand.
Share Price
$0.12753134
Last synced: 2026-11-13
Market Cap
$51.65M
Change (1 day)
-0.77%
Change (1 year)
-13.11%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Specialty Natural Products Public Company Limited (SNPS)
Category
Healthcare
Operating Margin for Specialty Natural Products Public Company Limited (SNPS)
Operating Margin as of November 2026 TTM: 22.09%
According to Specialty Natural Products Public Company Limited's latest financial reports, its current operating margin (TTM) is 22.09%. At the end of 2025 the company had an operating margin of 21.79%.
Operating Margin history for Specialty Natural Products Public Company Limited from 2021 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 22.09% | 1.38% |
| 2025 | 21.79% | 5.27% |
| 2024 | 20.70% | 69.26% |
| 2023 | 12.23% | -34.91% |
| 2022 | 18.79% | -33.86% |
| 2021 | 28.41% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 59.80% | -97.29% |
US
|
|
| 31.60% | -98.57% |
SE
|
|
| 30.13% | -98.64% |
FR
|
|
| 29.76% | -98.65% |
HK
|
|
| 31.11% | -98.59% |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Specialty Natural Products Public Company Limited's operating margin
What is Specialty Natural Products Public Company Limited's operating margin?
Specialty Natural Products Public Company Limited's operating margin is 22.09%, as of Nov 2026.
What was Specialty Natural Products Public Company Limited's operating margin in 2025?
In 2025, Specialty Natural Products Public Company Limited's operating margin was 21.79%, compared with 20.70% in 2024.
How has Specialty Natural Products Public Company Limited's operating margin changed since 2021?
From 2021 to 2025, Specialty Natural Products Public Company Limited's operating margin was highest in 2021 (28.41%) and lowest in 2023 (12.23%).
How does Specialty Natural Products Public Company Limited's operating margin compare with similar companies?
Specialty Natural Products Public Company Limited's operating margin (22.09%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 59.80%.